These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15506677)

  • 1. Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus.
    Kadmon PM; Gruppuso PA
    J Pediatr Endocrinol Metab; 2004 Sep; 17(9):1185-93. PubMed ID: 15506677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study.
    Musholt PB; Schöndorf T; Pfützner A; Hohberg C; Kleine I; Fuchs W; Hehenwarter S; Dikta G; Kerschgens B; Forst T
    J Diabetes Sci Technol; 2009 Nov; 3(6):1442-50. PubMed ID: 20144400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ;
    JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The combination of insulin and metformin in obese patients with type-2 diabetes mellitus].
    Sánchez-Barba Izquierdo MI; Ibarra Rueda JM; Ruiz de Adana Pérez R
    Aten Primaria; 1999 Nov; 24(8):462-7. PubMed ID: 10630028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial.
    Bacha F; El Ghormli L; Arslanian S; Zeitler P; Laffel LM; Levitt Katz LE; Gandica R; Chang NT; Sprague JE; Macleish SA;
    Pediatr Diabetes; 2019 Nov; 20(7):871-879. PubMed ID: 31418516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.
    Malone JK; Kerr LF; Campaigne BN; Sachson RA; Holcombe JH;
    Clin Ther; 2004 Dec; 26(12):2034-44. PubMed ID: 15823767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial.
    Gao F; Ma X; Peng J; Lu J; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W; Zhou J
    Diabetes Technol Ther; 2020 Apr; 22(4):256-264. PubMed ID: 31638433
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of liraglutide on glycemic endpoints in people of Western European and South Asian descent with T2DM using multiple daily insulin injections: results of the MAGNA VICTORIA studies.
    Bizino MB; Jazet IM; van Eyk HJ; Rensen PCN; Geelhoed-Duijvestijn PH; Kharagjitsingh AV; Paiman EHM; Smit JW; Lamb HJ
    Acta Diabetol; 2021 Apr; 58(4):485-493. PubMed ID: 33399989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
    Rosenstock J; Rodbard HW; Bain SC; D'Alessio D; Seufert J; Thomsen AB; Svendsen CB; DeVries JH;
    J Diabetes Complications; 2013; 27(5):492-500. PubMed ID: 23746555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.
    Dailey G; Rosenstock J; Moses RG; Ways K
    Diabetes Care; 2004 Oct; 27(10):2363-8. PubMed ID: 15451901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation.
    Fujioka K; Pans M; Joyal S
    Clin Ther; 2003 Feb; 25(2):515-29. PubMed ID: 12749511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: a pilot study.
    Gómez R; Mokhashi MH; Rao J; Vargas A; Compton T; McCarter R; Chalew SA
    J Pediatr Endocrinol Metab; 2002; 15(8):1147-51. PubMed ID: 12387512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study.
    Bailey CJ; Bagdonas A; Rubes J; McMorn SO; Donaldson J; Biswas N; Stewart MW
    Clin Ther; 2005 Oct; 27(10):1548-61. PubMed ID: 16330291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control in youth-onset type 2 diabetes correlates with weight loss.
    Chang N; Yeh MY; Raymond JK; Geffner ME; Ryoo JH; Chao LC
    Pediatr Diabetes; 2020 Nov; 21(7):1116-1125. PubMed ID: 33103329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.
    Pandya BJ; Bron M; McCall T; Yu AP; Chen KS; Mattson ME; Wu EQ
    Curr Med Res Opin; 2011 Jan; 27(1):189-95. PubMed ID: 21142610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India.
    Krishnakumar S; Govindarajulu Y; Vishwanath U; Nagasubramanian VR; Palani T
    Diabetes Metab Syndr; 2020; 14(5):1379-1383. PubMed ID: 32755838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A statistical model to identify determinants of glycemic control in patients with type 2 diabetes with different pharmacotherapeutic profiles.
    Moura AM; Antunes M; Martins SO; Raposo JF
    PLoS One; 2020; 15(7):e0235376. PubMed ID: 32629460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.